A dedicated life science strategy consultancy
Founders’ Letter
Accelerating innovation in life science
Scientific and technological breakthroughs bring hope for treatment and cures of diseases previously untreatable. Ideas, which just a few decades ago appeared as vivid and utopian dreams, are now shaping a new reality.
A new reality for patients and their relatives. For governments, healthcare systems, and society at large. A new reality for established and upcoming life science companies that face essential new choices for how to adapt and evolve.
The life science industry is at the verge of unprecedented change. Catalyzing this change requires full attention to the big picture and the layers of complexity beneath it.
Biobridge Partners was founded to become a dedicated, integrated player in the life science ecosystem, serving pharmaceutical and biotech companies adapting for the future, and building connections between the established and the upcoming.
For you as a life science decision-maker, we want to help you solve your toughest problems, shoulder by shoulder. To help you look ahead, drive the necessary change, and prepare your company for the future.
For you as a Curious Thinker joining our team, we want to unleash your energy and drive for learning and development. To be a place for you to challenge the status quo, preparing you for a thrilling and impactful career in the life science industry.
For you as a citizen, patient or relative, we want to make a positive impact on your life by forging new partnerships and collaborations that will improve your access to innovative treatments, diagnostics, and preventive measures.
For ourselves as founders, we want Biobridge Partners to become a vehicle for delivering true and positive impact. True impact to our clients, to our team, and to society.
Jonas & Daniel
Our Core Beliefs
Learning
Learning is the only true and sustainable source of competitive advantage
Dedication
Catalyzing large-scale positive change through life science requires industry-specialization
Integration
Embracing ecosystem integration and partnerships will be key in the future
Inspiration
Diversity of thought is a prerequisite for inspiring meaningful action and change
Daniel Schmidt
Daniel has 8+ years of strategy consulting experience with a predominant focus on commercial operations of life science companies. Daniel was previously part of Monitor Deloitte’s European Life Science Practice, and the Life Science Lead of Deloitte Consulting Denmark. He has deep expertise within market access, product launch, brand strategy, and customer engagement. He has experience across many therapeutic areas, and has been working with small molecules, biologics, as well as cell and gene therapies.
Daniel holds a B.Sc. in International Business and an M.Sc. in Economics and Business Administration from Copenhagen Business School.
Jonas T. Karlsen, Ph.D.
Jonas is a life science strategy consultant and a scientist with a strong analytical foundation from a Ph.D. in biophysics. Prior to co-founding Biobridge Partners, Jonas worked in Monitor Deloitte’s strategy practice, and is experienced within corporate strategy and operating model design, market access, brand strategy, and corporate M&A, as well as private equity commercial due diligence and value realization.
Jonas holds a Ph.D. in biophysics from the Technical University of Denmark, DTU, and further studied at California Institute of Technology. Recipient of the Ministry of Sciences Elite Research Award.
.jpg)
Olivia Shen
Olivia is a life science strategy consultant with a predominant focus on the commercial functions of biopharma companies. Prior to joining Biobridge Partners, she worked in Monitor Deloitte’s strategy practice, and is experienced within both corporate and functional strategy.
Olivia holds an MSc in Development Studies from Copenhagen University and a BSc in Economics from University of Nottingham.
Florian Preis
Florian is a life science strategy consultant with a strong background in strategy and the pharmaceutical industry from his previous positions at Novo Nordisk and Monitor Deloitte. He has 3+ years of experience working in commercial functions and global finance.
Florian has an educational background from Denmark, the USA, and the UK. He holds an M.Sc. in Advanced Economics and Finance from Copenhagen Business School with further studies at the University of Michigan’s Ross Business School as well as a B.Sc. in Economics and Finance from the University of Strathclyde.
.jpg)
Johannes Bæk Christensen
Johannes is a strategy consultant with 5+ years of experience from previous positions at Monitor Deloitte and Struensee & Co. He has great insight into corporate strategy, channel strategy, operating model design, and strategic cost out in both the public and the private sector.
Johannes holds a M.Sc. in Economics from Copenhagen University.
Bo Wiinberg, Ph.D.
Bo has 15+ years of experience from life sciences. He is specialized in the R&D value chain and has previously held several senior leadership positions across R&D, including in drug discovery & development, strategy, portfolio management and innovation, latest within a transformational stem cell R&D unit.
Bo predominantly advices R&D organizations, biotechs, and venture capital firms on topics related to drug discovery and development, operating models, innovation and sourcing of assets and technology, as well as commercialization roadmaps.
Bo is a DVM and holds a Ph.D. in Inflammation & Hemostasis from University of Copenhagen and an executive education from IMD.
Jesper Johansen
Jesper has 10+ years of experience as a life science consultant and has most recently been leading the Nordic Life Science Strategy team at Accenture. He is experienced working across the pharma value chain, with spikes in operational and commercial strategy, product launch and go-to-market strategy, and operating model design in R&D and innovation-driven organizations.
Jesper holds an Executive MBA from Copenhagen Business School.
Nicolai Hesdorf
Nicolai Hesdorf is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held leadership roles at both Deloitte and Accenture, including Equity Partner and Nordic Lead for Deloitte's strategy unit Monitor Deloitte and Partner and Managing Director of Accenture Denmark. Throughout his career, Nicolai has helped numerous companies develop and implement successful strategies to achieve their business goals and as chair of the board of directors at Biobridge Partners, he will be a key catalyst for our ambitious growth journey.